更正：用于筛选反义寡核苷酸在杜氏肌营养不良症中外显子跳跃疗效的野生型小鼠模型。
Correction: Wild-Type Mouse Models to Screen Antisense Oligonucleotides for Exon-Skipping Efficacy in Duchenne Muscular Dystrophy.
作者信息
Cao Limin, Han Gang, Gu Ben, Yin HaiFang
出版信息
PLoS One. 2018 Nov 15;13(11):e0207817. doi: 10.1371/journal.pone.0207817. eCollection 2018.
Abstract
[This corrects the article DOI: 10.1371/journal.pone.0111079.].
摘要
[本文更正了文章的数字对象标识符：10.1371/journal.pone.0111079。]
相似文献
1
Correction: Wild-Type Mouse Models to Screen Antisense Oligonucleotides for Exon-Skipping Efficacy in Duchenne Muscular Dystrophy.
PLoS One. 2018 Nov 15;13(11):e0207817. doi: 10.1371/journal.pone.0207817. eCollection 2018.
2
Correction: Correction: Wild-Type Mouse Models to Screen Antisense Oligonucleotides for Exon-Skipping Efficacy in Duchenne Muscular Dystrophy.
PLoS One. 2019 Feb 20;14(2):e0212820. doi: 10.1371/journal.pone.0212820. eCollection 2019.
3
Designing Effective Antisense Oligonucleotides for Exon Skipping.
Methods Mol Biol. 2018;1687:143-155. doi: 10.1007/978-1-4939-7374-3_10.
4
Tips to Design Effective Splice-Switching Antisense Oligonucleotides for Exon Skipping and Exon Inclusion.
Methods Mol Biol. 2018;1828:79-90. doi: 10.1007/978-1-4939-8651-4_5.
5
In vivo comparison of 2'-O-methyl phosphorothioate and morpholino antisense oligonucleotides for Duchenne muscular dystrophy exon skipping.
J Gene Med. 2009 Mar;11(3):257-66. doi: 10.1002/jgm.1288.
6
Quantitative Antisense Screening and Optimization for Exon 51 Skipping in Duchenne Muscular Dystrophy.
Mol Ther. 2017 Nov 1;25(11):2561-2572. doi: 10.1016/j.ymthe.2017.07.014. Epub 2017 Jul 28.
7
Antisense-induced exon skipping for duplications in Duchenne muscular dystrophy.
BMC Med Genet. 2007 Jul 5;8:43. doi: 10.1186/1471-2350-8-43.
8
In silico screening based on predictive algorithms as a design tool for exon skipping oligonucleotides in Duchenne muscular dystrophy.
PLoS One. 2015 Mar 27;10(3):e0120058. doi: 10.1371/journal.pone.0120058. eCollection 2015.
9
Development of antisense-mediated exon skipping as a treatment for duchenne muscular dystrophy.
Ann N Y Acad Sci. 2009 Sep;1175:71-9. doi: 10.1111/j.1749-6632.2009.04973.x.
10
An Overview of Recent Advances and Clinical Applications of Exon Skipping and Splice Modulation for Muscular Dystrophy and Various Genetic Diseases.
Methods Mol Biol. 2018;1828:31-55. doi: 10.1007/978-1-4939-8651-4_2.
引用本文的文献
1
Correction: Correction: Wild-Type Mouse Models to Screen Antisense Oligonucleotides for Exon-Skipping Efficacy in Duchenne Muscular Dystrophy.
PLoS One. 2019 Feb 20;14(2):e0212820. doi: 10.1371/journal.pone.0212820. eCollection 2019.
本文引用的文献
1
Wild-type mouse models to screen antisense oligonucleotides for exon-skipping efficacy in Duchenne muscular dystrophy.
PLoS One. 2014 Nov 3;9(11):e111079. doi: 10.1371/journal.pone.0111079. eCollection 2014.
Zotero 插件